The NEURO-TTRansform Study

The NEURO-TTRansform Study is a Phase 3 clinical trial of an investigational antisense drug called AKCEA-TTR-LRx for people living with hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN).

If you have been diagnosed with hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN) and keen to be involved in the study please click on this link more details,

STUDY ENROLMENT

Print Friendly, PDF & Email

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: